Skip to content

Phase II study of stereotactic MR-guided online adaptive radiosurgery for kidney cancer

Phase II study of stereotactic MR-guided online adaptive radiosurgery for kidney cancer - Stereotactic adaptive radiosurgery for kidney cancer

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056588
Enrollment
25
Registered
2025-02-10
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney cancer(primary kidney cancer)

Interventions

To perform stereotactic MR-guided online adaptive radiosurgery for kidney cancer.

Sponsors

Tohoku University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Primary kidney cancer which has pathological diagnosis or clinical diagnosis (2)T1N0M0, or T1NanyMany and all lymph nodes and distant metastases have been controlled (3)Performance status is from 0 to 2 (4)Twenty or more years old (5)Urologists and radiologists agree to perform stereotactic radiotherapy instead of surgery, cryotherapy or active surveillance, or patient refused surgery and cryotherapy. (6)Written informed consent

Exclusion criteria

Exclusion criteria: (1)Radiation oncologists judge not to have a tolerance or not to be suitable for stereotacitc radiotherapy because of coexisting illness (2)Double cancer or past history of double cancer within 3 years. (3)Implanted metal in the body (4)Mental disorder, especially claustrophobiady (5)Infection (6)Pregnant or lactating woman, likelihood of pregnancy (7)Past-radiotherapy history for the same site (8)Patients with psychiatric illness or symptoms making participation in the study difficult to assess

Design outcomes

Primary

MeasureTime frame
One-year local control rate.

Secondary

MeasureTime frame
One-year overall survival rate, 1-year progression free survival rate and incidences of serious adverse events

Countries

Japan

Contacts

Public ContactTakaya Yamamoto

Tohoku University Hospital Department of Radiation Oncology

takaya.yamamoto.c3@tohoku.ac.jp+81-22-717-7312

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026